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Introduction: Nowadays a significant (app. 70%) number of drugs entering the market present 
low solubility in water (1). To minimize this problem, which impacts on dissolution, absorption, 
and therapeutic efficacy of drugs in dosage forms, several techniques have been employed, 
namely micronization or selection of a defined polymorph (2). The production of amorphous 
solid dispersions of drugs is regarded as one of the most powerful approaches for solubility 
enhancement. However, since amorphous substances are thermodynamically unstable, they 
tend to convert back into a stable crystalline lattice. This conversion can be delayed by 
combination of substances producing co-amorphous mixtures (2,3), due to bond formation 
between individual molecules, thus preventing crystal formation (2). The aim of the present 
study was to assess the potential of several excipients for the production of stable co-
amorphous containing olanzapine, a poorly water soluble antipsychotic drug.  
Materials and Methods: Mixtures of olanzapine with L-arginine, L-tryptophan, L-proline, citric 
acid, oxalic acid, tartaric acid, saccharin and caffeine were produced in a 1:1 molar ratio by the 
quench cooling of molten mixtures with liquid nitrogen. The mixtures were characterized by near 
infrared spectroscopy (NIR, ABB TLA 20), before and after quench cooling, to detect 
interactions between the molecules of each compound and differential scanning calorimetry 
(DSC, TA Instruments QA200, 0-250ºC, at 10ºC/min) to assess the formation of different 
polymorphic forms of olanzapine. Solubility studies were performed to evaluate the increase in 
water solubility of the drug. 
Results: Thermal analysis revealed that mixtures of olanzapine and L-proline, citric acid, tartaric 
acid and saccharin were the most promising for the production of co-amorphous mixtures. NIR 
spectra of these mixtures show an increase in the intensity of absorbance in OH regions (5200-
5100cm-1) and the appearance of a band related to NH-OH interaction, likely due to bond 
formation. The thermograms derived from calorimetric studies did not show any endotherms 
related to melting of materials. Furthermore, the systems resulted in increased drug solubility, 
ranging between 28 for L-proline and 57 times when saccharin was used. 
Discussion and Conclusions: The screening of the excipients for the potential production of 
co-amorphous mixtures containing olanzapine allowed the selection of L-proline, citric acid, 
tartaric acid and saccharin. The binary mixtures were characterized by strong absorbance 
intensities at the wavenumber corresponding to OH and NH bonds, indicative of the 
establishment of hydrogen bonds between these groups within the drug:excipient molecules.  
In conclusion, the increased solubility, the absence of endotherms related to melting and 
hydrogen bond formation, strongly suggests co-amorphization of olanzapine with the excipients 
tested.  
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